Product Description

Comprehensive in vitro evaluation of small molecules using robust, disease-relevant assay platforms to support hit identification, lead optimization, and mechanism-of-action studies.

We provide flexible and scalable compound testing and profiling services to support early drug discovery programs. Our platforms enable reliable evaluation of small molecules across a wide range of cell-based, biochemical, and functional assays, delivering high-quality data to guide informed decision-making.

From single-point screening to full dose–response characterization, our experienced scientists work closely with clients to ensure assays are tailored to specific targets, pathways, and project goals.

What We Offer

• Primary & secondary compound screeningSingle-concentration or multi-dose formats for hit identification and confirmation

• Dose–response and potency profilingIC₅₀ / EC₅₀ determination with robust assay statistics

• Cell-based functional assaysGPCR signaling, reporter assays, pathway-specific readouts, and phenotypic responses

• Target selectivity & profiling studiesCross-target or pathway-level evaluation to support lead optimization

• Customized assay executionAssays designed or adapted based on your target biology and project needs